33rd ICPE: Weighing the Benefits & Risks: The Science and Methods of Benefit-Risk Assessment in Drug Development & Regulatory Decision-Making

Brett Hauber, RTI – Health Solutions

Tarek Hammad, FISPE, Merck Research Laboratories

Juhaeri Juhaeri, Sanofi

Rebecca Noel, Eli Lilly & Company

Components visible upon registration.